Clear cell papillary renal cell carcinoma: A clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 12, 2013, Pages 2936-2942

  Shi, Shan Shan ^a   Shen, Qin ^a   Xia, Qiu Yuan ^a   Tu, Pin ^a   Shi, Qun Li ^a   Zhou, Xiao Jun ^a   Rao, Qiu ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Clear cell papillary renal cell carcinoma; Fluorescence in situ hybridization; Immunohistochemistry; Renal cell carcinoma; Ultrastructure; VHL

Indexed keywords

CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TUMOR ANTIGEN; TUMOR MARKER; VHL PROTEIN, HUMAN; VON HIPPEL LINDAU PROTEIN;

ADULT; AGED; ARTICLE; CHEMISTRY; CHROMOSOME 3; CHROMOSOME DELETION; CLEAR CELL PAPILLARY RENAL CELL CARCINOMA; ELECTRON MICROSCOPY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; MUTATION; NEPHRECTOMY; NUCLEOTIDE SEQUENCE; PHENOTYPE; ULTRASTRUCTURE; VHL;

CLEAR CELL PAPILLARY RENAL CELL CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; RENAL CELL CARCINOMA; ULTRASTRUCTURE; VHL;

ADULT; AGED; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, RENAL CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MUTATION; NEPHRECTOMY; PHENOTYPE; TUMOR MARKERS, BIOLOGICAL; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84888804451     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H and Amin MB. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006; 30: 141-53.
2. Gobbo S, Eble JN, Grignon DJ, Martignoni G, MacLennan GT, Shah RB, Zhang S, Brunelli M and Cheng L. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol 2008; 32: 1239-1245.
3. Aydin H, Chen L, Cheng L, Vaziri S, He H, Ganapathi R, Delahunt B, Magi-Galluzzi C and Zhou M. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol 2010; 34: 1608-1621.
4. Gobbo S, Eble JN, Maclennan GT, Grignon DJ, Shah RB, Zhang S, Martignoni G, Brunelli M and Cheng L. Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am J Surg Pathol 2008; 32: 1780-1786.
5. Rao Q, Cheng L, Xia QY, Liu B, Li L, Shi QL, Shi SS, Yu B, Zhang RS, Ma HH, Lu ZF, Tu P and Zhou XJ. Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): a clinicopathological study emphasizing extrarenal PEComas. Histopathology 2013; 62: 642-50.
6. Rao Q, Zhang XM, Tu P, Xia QY, Shen Q, Zhou XJ and Shi QL. Renal cell carcinomas with t(6;11)(p21;q12) presenting with tubulocystic renal cell carcinoma-like features. Int J Clin Exp Pathol 2013; 6: 1452-7.
7. Zhou J, Wang J, Li N, Zhang X, Zhou H, Zhang R, Ma H and Zhou X. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma. Pathol Int 2010; 60: 452-458.
8. Rao Q, Liu B, Cheng L, Zhu Y, Shi QL, Wu B, Jiang SJ, Wang Y, Wang X, Yu B, Zhang RS, Ma HH, Lu ZF, Tu P, Wang JD and Zhou XJ. Renal cell carcinomas with t(6;11)(p21;q12): A clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization. Am J Surg Pathol 2012; 36: 1327-1338.
9. Klatte T, Said JW, Seligson DB, Rao PN, de Martino M, Shuch B, Zomorodian N, Kabbinavar FF, Belldegrun AS and Pantuck AJ. Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features. J Urol 2011; 185: 30-35.
10. Adam J, Couturier J, Molinie V, Vieillefond A and Sibony M. Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases. Histopathology 2011; 58: 1064-1071.
11. Rohan SM, Xiao Y, Liang Y, Dudas ME, Al-Ahmadie HA, Fine SW, Gopalan A, Reuter VE, Rosenblum MK, Russo P and Tickoo SK. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol 2011; 24: 1207-20.
12. Kuroda N, Shiotsu T, Kawada C, Shuin T, Hes O, Michal M, Ohe C, Mikami S and Pan CC. Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study. Ann Diagn Pathol 2011; 15: 282-285.
13. Wolfe A, Dobin SM, Grossmann P, Michal M and Donner LR. Clonal trisomies 7, 10 and 12, normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney. Virchows Arch 2011; 459: 457-463.
14. Inoue T, Matsuura K, Yoshimoto T, Nguyen LT, Tsukamoto Y, Nakada C, Hijiya N, Narimatsu T, Nomura T, Sato F, Nagashima Y, Kashima K, Hatakeyama S, Ohyama C, Numakura K, Habuchi T, Nakagawa M, Seto M, Mimata H and Moriyama M. Genomic profiling of renal cell carcinoma in patients with end-stage renal disease. Cancer Sci 2012; 103: 569-576.